Iktos

Iktos is a company that leverages artificial intelligence to expedite the drug discovery process. The company's primary focus is on improving the speed and efficiency at which new treatments are developed by using machine learning to design novel molecules. Through its AI technology, Iktos can predict the properties of billions of yet-to-be-synthesized molecules, significantly reducing the time and resource requirements typically associated with drug discovery.

The company's AI technology is built around the concept of generative modeling, a process that can generate new virtual molecules with optimal properties. Their services are offered to pharmaceutical and biotechnology companies looking to streamline their drug discovery endeavors. With its AI-driven solutions, Iktos is fundamentally transforming the way new drugs are discovered and developed, making the process faster and more cost-effective.